InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (33 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
33
T+90 hit rate
0%
T+90 mean return
-26.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Watts Ryan J., Chairman & CEO. Insider active across 1 company, notably Denali Therapeutics Inc.. Cumulatively, 43 reports have been published. Breakdown: 0 buy · 33 sells. Total volume traded: €8.4m. History available since 3 May 2021. The latest transaction was disclosed on 6 January 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations43 total
29,266 shares@ US$20.226.8% of flowCommon StockSEC:0001714899-25-000049:0
54,180 shares0Common StockSEC:0001714899-25-000028:0
40,000 shares@ US$0.680.3% of flowCommon StockSEC:0001714899-24-000206:0
2,260 shares@ US$23.790.6% of flowCommon StockSEC:0001714899-24-000197:0
40,000 shares0Common StockSEC:0001714899-24-000097:0
9,589 shares@ US$17.291.8% of flowCommon StockSEC:0001714899-24-000061:0
7,818 shares@ US$19.781.7% of flowCommon StockSEC:0001714899-24-000039:0
17,483 shares@ US$19.433.7% of flowCommon StockSEC:0001714899-24-000035:0
89,520 shares0Common StockSEC:0001714899-24-000008:0
2,309 shares@ US$22.590.6% of flowCommon StockSEC:0001714899-23-000133:0
2,526 shares@ US$0.680.0% of flowCommon StockSEC:0001714899-23-000123:0
50,000 shares@ US$0.680.4% of flowCommon StockSEC:0001714899-23-000105:0
200 shares@ US$0.680.0% of flowCommon StockSEC:0001714899-23-000066:0
8,815 shares@ US$30.092.9% of flowCommon StockSEC:0001714899-23-000029:0
3,433 shares@ US$30.591.2% of flowCommon StockSEC:0001714899-23-000023:0
4,800 shares@ US$28.441.5% of flowCommon StockSEC:0001714899-23-000013:0
82,240 shares0Common StockSEC:0001209191-23-002179:0
2,404 shares@ US$33.220.9% of flowCommon StockSEC:0001714899-22-000129:0
9,491 shares@ US$34.720.011% mcap4.4% of flowCommon StockSEC:0001714899-22-000042:0
2,719 shares@ US$37.55190.0035% mcap1.4% of flowCommon StockSEC:0001714899-22-000035:0
2,719 shares@ US$37.55190.0035% mcap2.9% of flowCommon StockSEC:0001714899-22-000035
5,007 shares@ US$44.780.0077% mcap6.3% of flowCommon StockSEC:0001714899-22-000008
5,007 shares@ US$44.780.0077% mcap3.0% of flowCommon StockSEC:0001714899-22-000008:0
62,000 shares0Common StockSEC:0001714899-22-000002
62,000 shares0Common StockSEC:0001714899-22-000002:0
25 of 43 declarations
About Watts Ryan J.
Ryan J. Watts is an executive at Denali Therapeutics Inc.
